ANTIMICROBIAL ACTIVITY OF FOSFOMYCIN-TOBRAMYCIN COMBINATION AGAINST PSEUDOMONAS AERUGINOSA ISOLATES ASSESSED BY TIME-KILL ASSAYS AND MUTANT PREVENTION CONCENTRATIONS

ANTIMICROBIAL ACTIVITY OF FOSFOMYCIN-TOBRAMYCIN COMBINATION AGAINST PSEUDOMONAS AERUGINOSA ISOLATES ASSESSED BY TIME-KILL ASSAYS AND MUTANT PREVENTION CONCENTRATIONS

Saved in:

Bibliographic Details
Main Authors:	M. .. Diez-Aguilar, M. I. Morosini, A. P. Tedim, I. .. Rodriguez, Z. .. Aktas, R. .. Cantón
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/643
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria
by: Guergana Petrova, et al.
Published: (2016-11-01)

Effect of daphnetin combined with tobramycin on Pseudomonas aeruginosa biofilm infection in vitro and in vivo
by: Dingbin Li, et al.
Published: (2025-08-01)

Comparison of microbroth dilution and e-test methods for detecting Fosfomycin susceptibility in pseudomonas aeruginosa
by: Gongqing Song, et al.
Published: (2025-06-01)

Pulmonary delivery of excipient-free tobramycin DPIs for the treatment of Pseudomonas aeruginosa lung infection with CF
by: Song Cheng, et al.
Published: (2025-06-01)

Anaerobiosis and Mutations Can Reduce Susceptibility of <i>Pseudomonas aeruginosa</i> to Tobramycin Without Reducing the Cellular Concentration of the Antibiotic
by: Woravimol Krittaphol, et al.
Published: (2025-02-01)

An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/Avibactam, And Tobramycin Against Carbapenem-Resistant Pseudomonas Aeruginosa
by: Bekir Özer, et al.
Published: (2024-12-01)

Nucleotide coordinated polymers, a ROS-based immunomodulatory antimicrobial, doubly kill Pseudomonas aeruginosa biofilms of implant infections
by: Jinghuang Chen, et al.
Published: (2025-02-01)

Recurrent diffuse panbronchiolitis after lung transplantation: Off-label use of inhaled tobramycin for Pseudomonas aeruginosa control in a transplant recipient
by: Shin Tanaka, et al.
Published: (2025-07-01)

An anticipatory mechanism enhances the cooperative behaviors of quorum sensing mutants in Pseudomonas aeruginosa.
by: Min Yuan, et al.
Published: (2025-04-01)

Diversification of <i>Pseudomonas aeruginosa</i> After Inhaled Tobramycin Therapy of Cystic Fibrosis Patients: Genotypic and Phenotypic Characteristics of Paired Pre- and Post-Treatment Isolates
by: Dayana Borisova, et al.
Published: (2025-03-01)

Production and Antimicrobial Activities of Pyocyanin Extracts from Pseudomonas aeruginosa
by: Dhanyashree Rai, et al.
Published: (2024-12-01)

R-pyocins as targeted antimicrobials against Pseudomonas aeruginosa
by: Madeline Mei, et al.
Published: (2025-02-01)

Nutrient conditions affect antimicrobial pharmacodynamics in Pseudomonas aeruginosa
by: Maik Kok, et al.
Published: (2025-01-01)

THE CORRESPONDENCE OF THE CARBAPENEMASE GENOTYPE AND PHENOTYPIC ANTIMICROBIAL PROFILES OF PSEUDOMONAS AERUGINOSA
by: N. Bahniuk, et al.
Published: (2023-12-01)

Evaluation of the Anti-Infectious Activity of the Complex Based on Quantum Dots InP / ZnSe / ZnS 650 and Tobramycin Against <i>Pseudomonas Aeruginosa</i> Infection of the Cornea. Experimental Research
by: O. V. Shilovskikh, et al.
Published: (2023-04-01)

Selection of Pseudomonas aeruginosa for biosurfactant production and studies of its antimicrobial activity
by: H.S. El-Sheshtawy, et al.
Published: (2014-03-01)

Aspartic acid unveils as antibiofilm agent and tobramycin adjuvant against mucoid and small colony variants of Pseudomonas aeruginosa isolates in vitro within cystic fibrosis airway mucus
by: Rosana Monteiro, et al.
Published: (2025-06-01)

Murepavadin Enhances the Killing Efficacy of Ciprofloxacin against <i>Pseudomonas aeruginosa</i> by Inhibiting Drug Efflux
by: Xiaoya Wei, et al.
Published: (2024-08-01)

Fc-modification of anti-PcrV gene-encoded antibodies modulates complement-mediated killing of Pseudomonas aeruginosa
by: Jillian Eisenhauer, et al.
Published: (2025-07-01)

Report concerning results of proficiency testing laboratory on assay of tobramycine and nystatin by microbiological method
by: Simona Sturzu, et al.
Published: (2013-05-01)

Evaluation of FASTinov for rapid antimicrobial susceptibility testing in Pseudomonas aeruginosa
by: Carmen Cintora-Mairal, et al.
Published: (2025-08-01)

Antimicrobial photodynamic inactivation of Pseudomonas aeruginosa persister cells and biofilms
by: Mona Mahmoud, et al.
Published: (2025-02-01)

Antimicrobial Potential of Extract from a Pseudomonas aeruginosa Isolate
by: Francis Kwaku Dzideh Amankwah, et al.
Published: (2022-01-01)

Evolution of Resistant Mutants in <i>Pseudomonas aeruginosa</i> Persister Cells Under Meropenem Treatment
by: Jie Feng, et al.
Published: (2025-07-01)

Extracellular GroEL Promotes adherence of ΔrhlA mutant to inert surfaces in Pseudomonas aeruginosa
by: Sebnem Bukavaz
Published: (2019-02-01)

Molecular Study of Antimicrobial Bacteriocins Isolated from Lactobacillus on Pseudomonas aeruginosa
by: Noor Ali Faleh, et al.
Published: (2024-01-01)

Biosynthesis of Silver Nanoparticles by Pseudomonas aeruginosa and Evaluation of Their Antibacterial Activity and Cytotoxicity Assay Properties
by: Dalya Huseen, et al.
Published: (2024-06-01)

Experience of the use of tobramycin for inhalation in children with cystic fibrosis
by: A. V. Orlov, et al.
Published: (2012-02-01)

Rose Bengal photodynamic antimicrobial therapy as an adjunct treatment for Pseudomonas aeruginosa infectious necrotizing scleritis
by: Salomon Merikansky, et al.
Published: (2025-06-01)

Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics
by: Ariane Khaledi, et al.
Published: (2020-02-01)

The antimicrobial efficacy of rutin encapsulated chitosan versus multidrug-resistant Pseudomonas aeruginosa
by: Helia Ramezani, et al.
Published: (2025-07-01)

Anti-Mutant Efficacy of Combination Therapy with Doripenem and Levofloxacin: <i>In Vitro</i> Model Studies with <i>Pseudomonas Aeruginosa</i>
by: M. V. Golikova, et al.
Published: (2021-06-01)

Novel Fosfomycin Resistance Mechanism in <i>Pseudomonas entomophila</i> Due to Atypical Pho Regulon Control of GlpT
by: Laura Sánchez-Maroto, et al.
Published: (2024-10-01)

Fosfomycin susceptibility in multidrug resistant uropathogens: A retrospective study in the era of antimicrobial resistance
by: Jasleen Kaur, et al.
Published: (2025-04-01)

Multidrug-resistant Pseudomonas aeruginosa in immunocompromised cancer patients: epidemiology, antimicrobial resistance, and virulence factors
by: Asmaa Abdulhak, et al.
Published: (2025-06-01)

Pseudomonas aeruginosa and Its Pathogenicity
by: Nida Nur Urgancı, et al.
Published: (2022-04-01)

ExoS effector in Pseudomonas aeruginosa Hyperactive Type III secretion system mutant promotes enhanced Plasma Membrane Rupture in Neutrophils.
by: Arianna D Reuven, et al.
Published: (2025-04-01)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01)

Comparison of Antibacterial Activities of Tobramycin Inhalation Solutions
by: V. V. Pisarev
Published: (2020-05-01)

Inhaled Tobramycin in the Treatment of Severe Nosocomial Pneumonias
by: V. V. Moroz, et al.
Published: (2012-04-01)